118 related articles for article (PubMed ID: 17255975)
1. Genetic factors associated with head and neck cancer.
Br Dent J; 2007 Jan; 202(2):58. PubMed ID: 17255975
[No Abstract] [Full Text] [Related]
2. Genetic and environmental factors in head and neck cancer genesis.
Báez A
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):174-200. PubMed ID: 18569329
[TBL] [Abstract][Full Text] [Related]
3. A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck.
Cohen EE
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4317-9. PubMed ID: 17671110
[No Abstract] [Full Text] [Related]
4. Aurora sheds light on head and neck squamous cell carcinoma.
Han H; Von Hoff DD
Clin Cancer Res; 2006 Sep; 12(17):5003-4. PubMed ID: 16951211
[No Abstract] [Full Text] [Related]
5. Molecular detection approaches for smoking associated tumors.
Hu YC; Sidransky D; Ahrendt SA
Oncogene; 2002 Oct; 21(48):7289-97. PubMed ID: 12379873
[TBL] [Abstract][Full Text] [Related]
6. Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism.
Alter BP; Joenje H; Oostra AB; Pals G
Arch Otolaryngol Head Neck Surg; 2005 Jul; 131(7):635-9. PubMed ID: 16027289
[No Abstract] [Full Text] [Related]
7. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility.
Lacko M; Oude Ophuis MB; Peters WH; Manni JJ
Anticancer Res; 2009 Feb; 29(2):753-61. PubMed ID: 19331232
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer.
Mithani SK; Taube JM; Zhou S; Smith IM; Koch WM; Westra WH; Califano JA
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4331-5. PubMed ID: 17671113
[TBL] [Abstract][Full Text] [Related]
9. Role of molecular markers and gene profiling in head and neck cancers.
Gold KA; Kim ES
Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
[TBL] [Abstract][Full Text] [Related]
10. A new marker determining clonal outgrowth.
Mao L
Clin Cancer Res; 2002 Jul; 8(7):2021-3. PubMed ID: 12114399
[No Abstract] [Full Text] [Related]
11. The role of genetic factors in predisposition to squamous cell cancer of the head and neck.
Jefferies S; Eeles R; Goldgar D; A'Hern R; Henk JM; Gore M
Br J Cancer; 1999 Feb; 79(5-6):865-7. PubMed ID: 10070882
[TBL] [Abstract][Full Text] [Related]
12. Tumour suppressor genes and head and neck cancer.
Jones AS
Adv Otorhinolaryngol; 2000; 56():249-60. PubMed ID: 10868242
[No Abstract] [Full Text] [Related]
13. Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review.
Patmore HS; Cawkwell L; Stafford ND; Greenman J
Ann Surg Oncol; 2005 Oct; 12(10):831-42. PubMed ID: 16132373
[TBL] [Abstract][Full Text] [Related]
14. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
[TBL] [Abstract][Full Text] [Related]
16. [Head and neck squamous cell cancer].
Tryggvason G; Sveinsson TE; Hjartarson H; Hálfdanarson TR
Laeknabladid; 2009 Oct; 95(10):671-80. PubMed ID: 19858546
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and head and neck cancer: a growing concern.
Gillespie MB; Smith J; Gibbs K; McRackan T; Rubinchik S; Day TA; Sutkowski N
J S C Med Assoc; 2008 Dec; 104(8):247-51. PubMed ID: 19326612
[TBL] [Abstract][Full Text] [Related]
19. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
